Anaphylaxis Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theAnaphylaxis Market from 2025 to 2034?
The rising prevalence of food allergies is expected to propel the growth of the anaphylaxis market going forward. Food allergies are immune system reactions triggered by certain foods, causing symptoms that range from mild to severe, including life-threatening anaphylaxis. The rising prevalence of food allergies are due to factors such as changing dietary habits, environmental influences, and improved awareness and diagnosis. Anaphylaxis treatment provides critical, life-saving intervention for food allergy patients by rapidly reversing severe allergic reactions, reducing symptoms such as swelling, difficulty breathing, and drop in blood pressure, ensuring immediate stabilization and preventing potentially fatal outcomes, while empowering patients with the tools for timely action in future allergic incidents. For instance, in September 2024, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, around 220 million people globally are affected by food allergies. A single food product can include multiple allergens, and individuals may be allergic to more than one type of food. Additionally, in May 2024, according to the Patterns and Prevalence of Adult Food Allergy (PAFA) report published by the Food Standards Agency (FSA), a UK-based non-ministerial department, over 30% of adults reported food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, equating to around 2.4 million people. Therefore, the rising prevalence of food allergies is driving the growth of the anaphylaxis market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp
#What Are the Key Projections for the CAGR of the Anaphylaxis Market From 2025 to 2034?
The anaphylaxis market has grown significantly. It is projected to expand from $3.24 billion in 2024 to $3.51 billion in 2025, reflecting a CAGR of 8.4%. The historical increase in market size can be attributed to the rising prevalence of food allergies, increased awareness of anaphylaxis, improvements in healthcare infrastructure, advancements in diagnosis and management, and the growing availability of epinephrine auto-injectors.
The anaphylaxis market size is set to expand significantly in the coming years. By 2029, it is forecasted to reach $4.81 billion, with a compound annual growth rate (CAGR) of 8.2%. Growth drivers include increasing urbanization and lifestyle changes, a rising incidence of anaphylaxis cases, growing disposable incomes in emerging markets, government funding for allergy research, and innovations in delivery systems for emergency treatment. Major trends anticipated include increased demand for injectable auto-injectors, integration of digital health solutions in anaphylaxis management, a greater focus on product affordability, advancements in preventative treatments and vaccines, and rising use of biologics for allergy treatment.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21096
How Are Market Trends and Innovations Revolutionizing theAnaphylaxis Industry in Recent Times?
In the anaphylaxis market, leading companies are focusing on developing advanced epinephrine nasal sprays to provide faster, more efficient drug delivery during emergencies. Epinephrine nasal spray is a medical device that administers epinephrine (adrenaline) through the nasal passages to treat severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a U.S.-based biotechnology company, received FDA approval for Neffy (epinephrine nasal spray), marking it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray offers a non-invasive alternative to traditional epinephrine autoinjectors, providing a more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating needles while delivering rapid, life-saving epinephrine during severe allergic reactions.
Which Key Market Players Are Shaping the Future and Growth of theAnaphylaxis Market?
Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report
What Are the Core Segments of the Anaphylaxis Market, and How Do They Contribute to Growth?
The anaphylaxis market covered in this report is segmented –
1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class
2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration
3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
Subsegments:
1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials
2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists
4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers
5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp
What Regions Are Dominating the Anaphylaxis Market Growth?
North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Anaphylaxis Market 2025, By The Business Research Company:
Vaccine Adjuvants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report
Enzyme Inhibitor Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/enzyme-inhibitor-global-market-report
Focal Segmental Glomerulosclerosis Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
